SMTL ID : 1iep.1 (1 other biounit)

CRYSTAL STRUCTURE OF THE C-ABL KINASE DOMAIN IN COMPLEX WITH STI-571.

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.10 Å

Oligo State

monomer

Ligands

4 x CL: CHLORIDE ION(Non-functional Binders)

CL.1: 1 residues within 4Å: Chain A: Y.10 Ligand excluded by PLIP CL.2: 3 residues within 4Å: Chain A: F.137, I.138 Ligands: STI.5 Ligand excluded by PLIP CL.3: 5 residues within 4Å: Chain A: F.95, M.96, T.97, G.150, E.151 Ligand excluded by PLIP CL.4: 5 residues within 4Å: Chain A: Q.30, Y.31, G.99, N.100 Ligands: STI.5 Ligand excluded by PLIP

1 x STI: 4-(4-METHYL-PIPERAZIN-1-YLMETHYL)-N-[4-METHYL-3-(4-PYRIDIN-3-YL-PYRIMIDIN-2-YLAMINO)-PHENYL]-BENZAMIDE(Non-covalent)

STI.5: 23 residues within 4Å: Chain A: L.26, Y.31, V.34, A.47, K.49, E.64, V.67, M.68, V.77, I.91, T.93, F.95, M.96, G.99, I.138, H.139, R.140, L.148, A.158, D.159, F.160 Ligands: CL.2, CL.4 13 PLIP interactions: 13 interactions with chain A Hydrophobic interactions: A:L.26, A:Y.31, A:K.49, A:I.91, A:T.93, A:D.159, A:F.160 Hydrogen bonds: A:E.64, A:T.93, A:M.96, A:D.159 Salt bridges: A:D.159 pi-Stacking: A:Y.31

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Nagar, B. et al., Crystal structures of the kinase domain of c-Abl in complex with the small molecule inhibitors PD173955 and imatinib (STI-571). Cancer Res. (2002)

Release Date

2001-04-18

Peptides

PROTO-ONCOGENE TYROSINE-PROTEIN KINASE ABL: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

PROTO-ONCOGENE TYROSINE-PROTEIN KINASE ABL

Related Entries With Identical Sequence